Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1320) 1320
Patent (1006) 1006
Conference Proceeding (72) 72
Publication (52) 52
Book / eBook (4) 4
Book Chapter (2) 2
Newspaper Article (2) 2
Book Review (1) 1
Dissertation (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (496) 496
performing operations (457) 457
transporting (457) 457
electricity (431) 431
female (374) 374
male (352) 352
middle aged (313) 313
aged (308) 308
index medicus (296) 296
physics (275) 275
lining machines (236) 236
printing (236) 236
stamps (236) 236
typewriters (236) 236
correction of typographical errors (235) 235
i.e. mechanisms printing otherwise than from a forme (235) 235
selective printing mechanisms (235) 235
adult (218) 218
oncology (191) 191
basic electric elements (146) 146
generation (131) 131
conversion or distribution of electric power (129) 129
risk factors (129) 129
mechanical engineering (116) 116
blasting (114) 114
heating (114) 114
lighting (114) 114
weapons (114) 114
electric communication technique (111) 111
japan (111) 111
general tagging of cross-sectional technologies spanning over several sections of the ipc (110) 110
general tagging of new technological developments (110) 110
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (110) 110
vehicles in general (107) 107
testing (106) 106
measuring (104) 104
treatment outcome (104) 104
calculating (103) 103
cancer (103) 103
computing (103) 103
counting (103) 103
medicine & public health (93) 93
analysis (87) 87
electric techniques not otherwise provided for (86) 86
aged, 80 and over (83) 83
electric digital data processing (82) 82
chemotherapy (81) 81
japan - epidemiology (79) 79
servicing, cleaning, repairing, supporting, lifting, ormanoeuvring of vehicles, not otherwise provided for (79) 79
engineering elements and units (78) 78
general measures for producing and maintaining effectivefunctioning of machines or installations (78) 78
thermal insulation in general (78) 78
research (77) 77
clinical trials (74) 74
dynamo-electric machines (74) 74
electric discharge tubes or discharge lamps (74) 74
chemistry (70) 70
metallurgy (68) 68
prospective studies (68) 68
human necessities (65) 65
technical subjects covered by former uspc (65) 65
follow-up studies (63) 63
diabetes (62) 62
technical subjects covered by former us classification (62) 62
animals (61) 61
antineoplastic combined chemotherapy protocols - therapeutic use (61) 61
risk (61) 61
mortality (59) 59
surgery (58) 58
care and treatment (57) 57
physical or chemical processes or apparatus in general (55) 55
hygiene (54) 54
medical or veterinary science (54) 54
prognosis (53) 53
hematology (52) 52
quality of life (52) 52
urology & nephrology (52) 52
diagnosis (51) 51
medical colleges (51) 51
wireless communications networks (51) 51
endocrinology & metabolism (50) 50
neoplasm staging (50) 50
therapy (50) 50
breast neoplasms - drug therapy (49) 49
survival rate (49) 49
breast cancer (48) 48
fixed constructions (48) 48
incidence (48) 48
gearing (47) 47
survival (47) 47
time factors (46) 46
disease-free survival (45) 45
technologies or applications for mitigation or adaptation againstclimate change (45) 45
apparatus for conversion between ac and ac, between ac and dc,or between dc and dc, and for use with mains or similar powersupply systems (43) 43
control or regulation thereof (43) 43
conversion of dc or ac input power into surge outputpower (43) 43
investigating or analysing materials by determining theirchemical or physical properties (43) 43
pharmacology & pharmacy (42) 42
coronary-heart-disease (40) 40
peripheral vascular disease (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2244) 2244
Japanese (118) 118
French (108) 108
German (94) 94
Chinese (67) 67
Korean (9) 9
Portuguese (6) 6
Spanish (2) 2
Dutch (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Izumo no Kuni tanjō
by Ōhashi, Yasuo, 1959- author
2016, Rekishi bunka raiburarī, ISBN 4642058362, Volume 436, 6, 267 pages
Izumo no Kuni fudoki | To 1185 | Japan History | Shimane-ken (Japan) History | Japan
Book
Details down arrow
2. Full Text Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
by Shinohara, Yukito, Prof and Katayama, Yasuo, Prof and Uchiyama, Shinichiro, Prof and Yamaguchi, Takenori, MD and Handa, Shunnosuke, Prof and Matsuoka, Kempei, MD and Ohashi, Yasuo, Prof and Tanahashi, Norio, Prof and Yamamoto, Hiroko, MD and Genka, Chokoh, MD and Kitagawa, Yasuhisa, Prof and Kusuoka, Hideo, MD and Nishimaru, Katsuya, MD and Tsushima, Motoo, MD and Koretsune, Yukihiro, MD and Sawada, Tohru, MD and Hamada, Chikuma, Prof and CSPS 2 Grp and CSPS 2 group
Lancet Neurology, The, ISSN 1474-4422, 2010, Volume 9, Issue 10, pp. 959 - 968
Summary Background The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence compared with placebo. We designed the second Cilostazol... 
Neurology | INFARCTION | CLOPIDOGREL | MANAGEMENT | METAANALYSIS | EFFICACY | SAFETY | RISK | PHOSPHODIESTERASE INHIBITOR | ISCHEMIC-STROKE | ANTIPLATELET THERAPY | CLINICAL NEUROLOGY | Cerebral Infarction - drug therapy | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Secondary Prevention - methods | Cerebral Infarction - complications | Cerebral Infarction - prevention & control | Aspirin - administration & dosage | Young Adult | Stroke - etiology | Tetrazoles - administration & dosage | Adult | Female | Aged | Stroke (Disease) | Prevention | Clinical trials | Aspirin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text SPS1-4Clinical Meaning and Operability of Endpoints in Cancer Clinical Trials: Example of Survey on RMST Threshold
by Ohashi, Yasuo
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial
by Takashima, Tsutomu, MD and Mukai, Hirofumi, Dr and Hara, Fumikata, MD and Matsubara, Nobuaki, MD and Saito, Tsuyoshi, MD and Takano, Toshimi, MD and Park, Youngjin, Prof and Toyama, Tatsuya, Prof and Hozumi, Yasuo, MD and Tsurutani, Junji, MD and Imoto, Shigeru, Prof and Watanabe, Takanori, MD and Sagara, Yoshiaki, MD and Nishimura, Reiki, MD and Shimozuma, Kojiro, Prof and Ohashi, Yasuo, Prof and SELECT BC Study Grp and SELECT BC Study Group
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 90 - 98
Summary Background Oral fluoropyrimidines are used for the first-line treatment of metastatic breast cancer to avoid severe adverse effects, although firm... 
Hematology, Oncology and Palliative Medicine | CAPECITABINE | LUNG-CANCER | ONCOLOGY | GASTRIC-CANCER | CYCLOPHOSPHAMIDE | JAPAN | EUROPEAN-ORGANIZATION | FLUOROURACIL | III TRIAL | ADJUVANT | Breast Neoplasms - surgery | Follow-Up Studies | Humans | Middle Aged | Fatigue - chemically induced | Receptors, Estrogen - analysis | Receptors, Progesterone - analysis | Taxoids - therapeutic use | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Liver Neoplasms - secondary | Neutropenia - chemically induced | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Tegafur - adverse effects | Tegafur - therapeutic use | Paclitaxel - adverse effects | Survival Rate | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Disease Progression | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Breast Neoplasms - pathology | Antimetabolites, Antineoplastic - adverse effects | Aged | Edema - chemically induced | Receptor, ErbB-2 - analysis | Health Status | Drug Combinations | Antimitotic agents | Medical colleges | Chemotherapy | Product development | Breast cancer | Metastasis | Antineoplastic agents | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study
by Ohno, Shinji and Mukai, Hirofumi and Narui, Kazutaka and Hozumi, Yasuo and Miyoshi, Yasuo and Yoshino, Hiroshi and Doihara, Hiroyoshi and Suto, Akihiko and Tamura, Motoshi and Morimoto, Takashi and Zaha, Hisamitsu and Chishima, Takashi and Nishimura, Reiki and Ishikawa, Takashi and Uemura, Yukari and Ohashi, Yasuo
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2019, Volume 176, Issue 3, pp. 631 - 635
While some studies show improved outcomes in clinical trial participants as compared to non-participants, existence of such a trial effect has not been proved... 
Medicine & Public Health | Prospective cohort study | Trial effect | Oncology | SELECT BC | Overall survival | Randomized control trial | CELL LUNG-CANCER | ONCOLOGY | CLINICAL-TRIALS | OUTCOMES | Medical research | Care and treatment | Chemotherapy | Prognosis | Patient outcomes | Clinical trials | Medicine, Experimental | Metastasis | Research | Comparative analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
by Sawaki, Akira and Ohashi, Yasuo and Omuro, Yasushi and Satoh, Taroh and Hamamoto, Yasuo and Boku, Narikazu and Miyata, Yoshinori and Takiuchi, Hiroya and Yamaguchi, Kensei and Sasaki, Yasutsuna and Nishina, Tomohiro and Satoh, Atsushi and Baba, Eishi and Tamura, Takao and Abe, Takashi and Hatake, Kiyohiko and Ohtsu, Atsushi
Gastric Cancer, ISSN 1436-3291, 7/2012, Volume 15, Issue 3, pp. 313 - 322
The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2)... 
Pathology | Medicine & Public Health | Gastroenterology | Oncology | Radiotherapy | Drug therapy | Surgical Oncology | Randomized controlled trial | Trastuzumab | Stomach neoplasms | CAPECITABINE | THERAPY | CISPLATIN | ONCOLOGY | PHASE-III | GASTROENTEROLOGY & HEPATOLOGY | CHEMOTHERAPY | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Stomach Neoplasms - metabolism | Male | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Esophageal Neoplasms - metabolism | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Proportional Hazards Models | Survival Rate | Stomach Neoplasms - drug therapy | Asian Continental Ancestry Group | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Medical colleges | Oncology, Experimental | College teachers | Metastasis | Research | Stomach cancer | Biometry | Chemotherapy | Epidermal growth factor | Analysis | Cross infection | Diabetes | Kidney diseases | Nosocomial infections | Public health | Cancer | Fluorouracil | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
by Uesaka, Katsuhiko, MD and Boku, Narikazu, Dr and Fukutomi, Akira, MD and Okamura, Yukiyasu, MD and Konishi, Masaru, MD and Matsumoto, Ippei, MD and Kaneoka, Yuji, MD and Shimizu, Yasuhiro, MD and Nakamori, Shoji, MD and Sakamoto, Hirohiko, MD and Morinaga, Soichiro, MD and Kainuma, Osamu, MD and Imai, Koji, MD and Sata, Naohiro, Prof and Hishinuma, Shoichi, MD and Ojima, Hitoshi, MD and Yamaguchi, Ryuzo, MD and Hirano, Satoshi, Prof and Sudo, Takeshi, MD and Ohashi, Yasuo, Prof and JASPAC 01 Study Grp and JASPAC 01 Study Group
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10041, pp. 248 - 257
Summary Background Although adjuvant chemotherapy with gemcitabine is standard care for resected pancreatic cancer, S-1 has shown non-inferiority to... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | III TRIAL | JAPAN | Injections, Intravenous | Carcinoma, Ductal - pathology | Deoxycytidine - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Pancreatectomy | Proportional Hazards Models | Male | Combined Modality Therapy | Lymphatic Metastasis | Oxonic Acid - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Carcinoma, Ductal - therapy | Tegafur - administration & dosage | Carcinoma, Ductal - mortality | Female | Aged | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - analogs & derivatives | Drug Combinations | Pancreatic Neoplasms - therapy | Antimitotic agents | Medical colleges | Antineoplastic agents | Pancreatic cancer | Adjuvant treatment | Cancer | Clinical trials | Chemotherapy | Cancer therapies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: A long-term phase II/III randomised controlled study
by Kaji, Ryuji and Imai, Takashi and Iwasaki, Yasuo and Okamoto, Koichi and Nakagawa, Masanori and Ohashi, Yasuo and Takase, Takao and Hanada, Takahisa and Shimizu, Hiroki and Tashiro, Kunio and Kuzuhara, Shigeki
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 2019, Volume 90, Issue 4, pp. 451 - 457
To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS). 373 patients with... 
Ostomy | Laboratories | Medical prognosis | Clinical trials | Amyotrophic lateral sclerosis | Systematic review | Homocysteine | Patients | Drug dosages | 1506 | Neuromuscular
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection
by Norio Sugaya and Yasuo Ohashi
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2010, Volume 54, Issue 6, pp. 2575 - 2582
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CLINICAL EFFECTIVENESS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IMPACT | H1N1 INFLUENZA | Oseltamivir - adverse effects | Influenza A Virus, H3N2 Subtype - drug effects | Virus Shedding - drug effects | Humans | Child, Preschool | Male | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Zanamivir - analogs & derivatives | Female | Influenza, Human - virology | Influenza B virus - drug effects | Influenza, Human - drug therapy | Child | Enzyme Inhibitors - adverse effects | Zanamivir - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Administration, Inhalation | Treatment Outcome | Influenza A Virus, H1N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Oseltamivir - administration & dosage | Antiviral Agents - adverse effects | Zanamivir - administration & dosage | Neuraminidase - antagonists & inhibitors | Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Predicting macro- and microvascular complications in type 2 diabetes: The japan diabetes complications study/the japanese elderly diabetes intervention trial risk engine
by Tanaka, Shiro and Tanaka, Sachiko and Iimuro, Satoshi and Yamashita, Hidetoshi and Katayama, Shigehiro and Akanuma, Yasuo and Yamada, Nobuhiro and Araki, Atsushi and Ito, Hideki and Sone, Hirohito and Ohashi, Yasuo and Japan Diabetes Complications Study Group and Japanese Elderly Diabetes Intervention Trial Group and for the Japan Diabetes Complications Study Group and the Japanese Elderly Diabetes Intervention Trial Group
Diabetes Care, ISSN 0149-5992, 05/2013, Volume 36, Issue 5, pp. 1193 - 1199
To develop and validate a risk engine that calculates the risks of macro- and microvascular complications in type 2 diabetes. We analyzed pooled data from two... 
Prospective Studies | Humans | Middle Aged | Coronary Disease - etiology | Diabetic Angiopathies - etiology | Coronary Disease - epidemiology | Male | Diabetes Mellitus, Type 2 - epidemiology | Asian Continental Ancestry Group | Stroke - etiology | Diabetic Retinopathy - epidemiology | Aged, 80 and over | Diabetes Complications - epidemiology | Adult | Diabetic Angiopathies - epidemiology | Female | Stroke - epidemiology | Aged | Diabetic Retinopathy - etiology | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Complications and side effects | Coronary heart disease | Risk factors | Studies | Cardiovascular disease | Diabetes | Mortality | Cholesterol | Epidemiology | Health Services Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial
by Ohuchi, Noriaki, Prof and Suzuki, Akihiko, PhD and Sobue, Tomotaka, Prof and Kawai, Masaaki, PhD and Yamamoto, Seiichiro, PhD and Zheng, Ying-Fang, PhD and Shiono, Yoko Narikawa, PhD and Saito, Hiroshi, PhD and Kuriyama, Shinichi, Prof and Tohno, Eriko, PhD and Endo, Tokiko, PhD and Fukao, Akira, Prof and Tsuji, Ichiro, Prof and Yamaguchi, Takuhiro, Prof and Ohashi, Yasuo, Prof and Fukuda, Mamoru, PhD and Ishida, Takanori, PhD and J-START Investigator Grp and J-START investigator groups
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10016, pp. 341 - 348
Summary Background Mammography is the only proven method for breast cancer screening that reduces mortality, although it is inaccurate in young women or women... 
Internal Medicine | WOMEN | RATES | MEDICINE, GENERAL & INTERNAL | COST | ASIA-PACIFIC REGION | ULTRASOUND | HARMS | DENSE BREASTS | ASSOCIATION | Early Detection of Cancer - methods | Carcinoma, Lobular | Humans | Japan | Middle Aged | Sensitivity and Specificity | Ultrasonography, Mammary | Adult | Female | Breast Neoplasms - diagnosis | Mammography | Carcinoma, Ductal, Breast | Prevention | Medical colleges | Care and treatment | Ultrasound imaging | Mortality | Breast cancer | Diagnosis | Health aspects | Cancer | Analysis | Clinical trials | Studies | Ultrasonic imaging | Breasts | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
by Sattar, Naveed, Prof and Preiss, David, Dr and Murray, Heather M, MSc and Welsh, Paul, PhD and Buckley, Brendan M, Prof and de Craen, Anton JM, PhD and Seshasai, Sreenivasa Rao Kondapally, MD and McMurray, John J, Prof and Freeman, Dilys J, PhD and Jukema, J Wouter, Prof and Macfarlane, Peter W, Prof and Packard, Chris J, Prof and Stott, David J, Prof and Westendorp, Rudi G, Prof and Shepherd, James, Prof and Davis, Barry R, Prof and Pressel, Sara L, MS and Marchioli, Roberto, Prof and Marfisi, Rosa Maria, Prof and Maggioni, Aldo P, Prof and Tavazzi, Luigi, Prof and Tognoni, Gianni, Prof and Kjekshus, John, Prof and Pedersen, Terje R, Prof and Cook, Thomas J, MS and Gotto, Antonio M, Prof and Clearfield, Michael B, Prof and Downs, John R, MD and Nakamura, Haruo, Prof and Ohashi, Yasuo, Prof and Mizuno, Kyoichi, Prof and Ray, Kausik K, MD and Ford, Ian, Prof
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9716, pp. 735 - 742
Summary Background Trials of statin therapy have had conflicting findings on the risk of development of diabetes mellitus in patients given statins. We aimed... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE ATORVASTATIN | EVENTS | AVERAGE | ADIPONECTIN | GLUCOSE | PRAVASTATIN | OUTCOMES | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | ROSUVASTATIN | Age Distribution | Age Factors | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Anticholesteremic Agents - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Randomized Controlled Trials as Topic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Female | Aged | Diabetes Mellitus, Type 2 - chemically induced | Complications and side effects | Dosage and administration | Diabetes | Research | Risk factors | Statins | Heart failure | Heart attacks | Sensitivity analysis | Hemodialysis | Cardiovascular disease | Clinical medicine | Patients | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights